ARGEF15; E5; Ephexin5; Vsm-RhoGEF
The ARHGEF15 gene currently has no well-established disease association; however, there is limited evidence supporting a correlation with autosomal dominant early infantile epileptic encephalopathy (PMID: 23647072).
Order this gene as a single gene test.
Invitae tests that include this gene:
Enzymes that utilize GTP as an energy source often require GTPase activating proteins (GAPs) to catalyze the conversion from GTP to GDP and guanine nucleotide exchange factors (GEFs) to promote turnover of the used GDP molecule and allow new GTP binding. The ARHGEF15 gene encodes a GEF expressed in the developing vasculature that interacts with the central regulator protein, Cdc42 (PMID: 23029280).
Invitae is a College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified clinical diagnostic laboratory performing full-gene sequencing and deletion/duplication analysis using next-generation sequencing technology (NGS).
Our sequence analysis covers clinically important regions of each gene, including coding exons, +/- 10 base pairs of adjacent intronic sequence in the transcript listed below. In addition, analysis covers the select non-coding variants specifically defined in the table below. Any variants that fall outside these regions are not analyzed. Any specific limitations in the analysis of these genes are also listed in the table below.
Our analysis detects most intragenic deletions and duplications at single exon resolution. However, in rare situations, single-exon copy number events may not be analyzed due to inherent sequence properties or isolated reduction in data quality. If you are requesting the detection of a specific single-exon copy number variation, please contact Client Services before placing your order.
|Gene||Transcript reference||Sequencing analysis||Deletion/Duplication analysis|